ACTA1 and inflammatory response: After bleomycin instillation, acute lung inflammation developed (day 7), and at this stage, we observed no change of α-SMA expression compared with the control group, but the expression of α-SMA increased following bleomycin treatment in lung tissues on days 14 and 21, which were significantly alleviated by treatment with mDASCs.